Evidence map›Paper›PMID 39012789›Full record

ArticleActa obstetricia et gynecologica Scandinavica2024

Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study.

Sofie Lindquist, Susanne K Kjær, Kirsten Frederiksen, Dorthe Ørnskov, Lone Kjeld Petersen, Christian Munk, Marianne Waldstrøm

Abstract read
In one paragraph

Article in Acta obstetricia et gynecologica Scandinavica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sofie LindquistUnit of Virus, Lifestyle, and Genes, Danish Cancer Institute, Copenhagen, Denmark.ORCID 0000-0001-5675-4184
Susanne K KjærUnit of Virus, Lifestyle, and Genes, Danish Cancer Institute, Copenhagen, Denmark.
Kirsten FrederiksenUnit of Statistics, Biostatistics, and Registry, Danish Cancer Institute, Copenhagen, Denmark.
Dorthe ØrnskovDepartment of Pathology, Odense University Hospital, Odense, Denmark.
Lone Kjeld PetersenDepartment of Obstetrics and Gynecology, Odense University Hospital, Odense, Denmark.
Christian MunkUnit of Virus, Lifestyle, and Genes, Danish Cancer Institute, Copenhagen, Denmark.
Marianne WaldstrømDepartment of Pathology, Aarhus University Hospital, Aarhus, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn Denmark, where human papillomavirus (HPV) -based cervical cancer screening is being implemented, the aim of this pilot implementation study was to test a specific screening algorithm, assess follow-up examination attendance, and measure the proportion of precancer lesions found in relation to the number of women referred for colposcopy. MATERIAL AND

methodsFrom May 2017 to December 2020, 36 417 women in the uptake area of the Department of Pathology, Vejle Hospital, Region of Southern Denmark, were included in the HPV group. Women positive for HPV16/18 irrespective of cytology and women positive for other high-risk HPV (hrHPV) types having concomitant abnormal cytology were referred directly to colposcopy. Women positive for other hrHPV types and normal cytology were referred to repeat screening after 12 months, and hrHPV negative to routine screening after three years. We obtained information on screening results and subsequent histological diagnosis from the Danish Pathology Databank through September 2022.

results3.6% of the women were referred to colposcopy after primary screening, 5% to repeat screening after 12 months, and 91.4% back to routine screening. High follow-up rates were observed: 96% attended colposcopy after primary screening, with 91% attending colposcopy after repeat screening. CIN3+ was detected at colposcopy following the primary screening in 28.1% of HPV16/18-positive women and 18.2% of those positive for other hrHPV types with concomitant abnormal cytology. Of the women with other hrHPV and simultaneous ASCUS/LSIL, 8% had CIN3+. At the repeat screening, 43% had become hrHPV negative, 55% were persistently positive for other hrHPV, and 2% had turned positive for HPV16/18. At the colposcopy following repeat screening, 10.1% of the women positive for other hrHPV were diagnosed with CIN3+, in comparison with 11.1% of the HPV16/18-positive women.

conclusionsIn this pilot implementation study, an algorithm for HPV-based screening was evaluated in a Danish setting. The results demonstrated high attendance at follow-up examinations and provided insights into the number of colposcopy referrals and the detection of CIN2 and CIN3+ cases. The results suggest that women testing positive for other hrHPV in combination with ASCUS/LSIL at primary screening could potentially be referred to repeat screening instead of an immediate colposcopy.

Indexed as

AlgorithmsColposcopyEarly Detection of CancerPapillomavirus InfectionsUterine Cervical NeoplasmsAdultAgedDenmarkFemaleHuman Papillomavirus VirusesHumansMass ScreeningMiddle AgedPilot ProjectsUterine Cervical Dysplasiacervical cancercervical intraepithelial neoplasiaHPV testinghuman papillomavirusscreening

Identifiers

PMID39012789
PMCPMC11324913

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.